دورية أكاديمية

Selective posterior cerebral artery amobarbital test: a predictor of memory following subtemporal selective amygdalohippocampectomy.

التفاصيل البيبلوغرافية
العنوان: Selective posterior cerebral artery amobarbital test: a predictor of memory following subtemporal selective amygdalohippocampectomy.
المؤلفون: Catapano, Joshua S., Whiting, Alexander C., Wang, Derrick J., Hlubek, Randall J., Labib, Mohamed A., Morgan, Clinton D., Brigeman, Scott, Fredrickson, Vance L., Cavalcanti, Daniel D., Smith, Kris A., Ducruet, Andrew F., Albuquerque, Felipe C.
المصدر: Journal of NeuroInterventional Surgery; Feb2020, Vol. 12 Issue 2, p165-169, 5p, 3 Charts
مصطلحات موضوعية: EPILEPSY surgery, TEMPORAL lobe surgery, AMOBARBITAL, BRAIN surgery, CAROTID artery, SEIZURES (Medicine), CLINICAL pathology, HEALTH facilities, HIPPOCAMPUS (Brain), NEUROPSYCHOLOGICAL tests, MEDICAL records, MEMORY disorders, POSTOPERATIVE period, RISK assessment, SPASMS, SURGICAL complications, PRE-tests & post-tests, RETROSPECTIVE studies, DESCRIPTIVE statistics, ACQUISITION of data methodology, POSTERIOR cerebral artery, DISEASE risk factors
مصطلحات جغرافية: ARIZONA
مستخلص: Background The selective posterior cerebral artery (PCA) amobarbital test, or PCA Wada test, is used to predict memory impairment after epilepsy surgery in patients who have previously had a failed internal carotid artery (ICA) amobarbital test. Methods Medical records from 2012 to 2018 were retrospectively reviewed for all patients with seizures who underwent a selective PCA Wada test at our institution following a failed or inconclusive ICA Wada test. standardized neuropsychological testing was performed before and during the Wada procedure and postoperatively in patients who underwent resection. Results Thirty-three patients underwent a selective PCA Wada test, with no complications. Twenty-six patients with medically refractory epilepsy had a seizure focus amenable to selective amygdalohippocampectomy (AHE). six patients (23%, n=26) had a failed PCA Wada test and did not undergo selective AHE, seven (27%) declined surgical resection, leaving 13 patients who underwent subtemporal selective AHE. Hippocampal sclerosis was found in all 13 patients (100%). Twelve patients (92%) subsequently underwent formal neuropsychological testing and all were found to have stable memory. Ten patients (77%) were seizure-free (Engel class i), with average follow-up of 13 months. Conclusion The selective PCA Wada test is predictive of memory outcomes after subtemporal selective AHE in patients with a failed or inconclusive ICA Wada test. Furthermore, given the low risk of complications and potential benefit of seizure freedom, a selective PCA Wada test may be warranted in patients with medically intractable epilepsy who are candidates for a selective AHE and who have a prior failed or inconclusive ICA Wada test. [ABSTRACT FROM AUTHOR]
Copyright of Journal of NeuroInterventional Surgery is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17598478
DOI:10.1136/neurintsurg-2019-014984